In Brief: Pharmacia & Upjohn/Oncotech
This article was originally published in The Gray Sheet
Executive Summary
Pharmacia & Upjohn/Oncotech: Sign agreement to jointly market Oncotech oncology laboratory services. In exchange for $5.5 mil., P&U receives North American co-marketing rights and "an option to extend these rights into other markets," P&U says. Under terms of the deal, "P&U will also support prospective clinical trials of Oncotech's prognostic marker tests" and Extreme Drug Resistance assay...